World-Class Scientific Review Committees
Our funding philosophy is to follow the most innovative and promising ideas that will lead to a cure for diseases of mind and sight.
Each year, our Scientific Review Committees, composed of renowned leaders in their fields, recommend new research opportunities for BrightFocus to advance our goal of defeating Alzheimer’s, macular degeneration, and glaucoma.
The following experts have served on each committee within the last five years:
Alzheimer's Disease Research Scientific Review Committee
Co-Chairs:
- David M. Holtzman, MD, Washington University School of Medicine
- Hui Zheng, PhD, Baylor College of Medicine
Committee Members:
- Beau Ances, MD, PhD, Washington University School of Medicine
- Katrin Andreasson, PhD, Stanford University
- Rhoda Au, PhD, Boston University School of Medicine
- David R. Borchelt, PhD, University of Florida
- Guojun Bu, PhD, Hong Kong University of Science and Technology
- Alice Chen-Plotkin, MD, University of Pennsylvania
- Laura Cox, PhD, Harvard Medical School, Brigham and Women’s Hospital
- Carlos Cruchaga, PhD, Washington University School of Medicine
- Mark Ebbert, PhD, University of Kentucky
- Steven Estus, PhD, University of Kentucky
- Douglas Galasko, MD, University of California, San Diego
- David Gate, PhD, Northwestern University
- Charles G. Glabe, PhD, University of California, Irvine
- Todd E. Golde, MD, PhD, Emory University
- John Hardy, PhD, FMedSci, FRS, University College London (UK)
- Julie Harris, PhD, Allen Institute
- S. Abid Hussaini, PhD, Columbia University
- Joanna Jankowsky, PhD, Washington University in St. Louis
- Lance Johnson, PhD, University of Kentucky
- Martin Kampmann, PhD, University of California, San Francisco
- Aimee Kao, MD, PhD, University of California, San Francisco
- Ksenia Kastanenka, PhD, Massachusetts General Hospital
- John “Keoni” Kauwe, PhD, Brigham Young University–Hawaii
Committee Members (cont.)
- Edward Koo, MD, University of California, San Diego
- Cynthia A. Lemere, PhD, Harvard Medical School, Brigham and Women’s Hospital
- Allan I. Levey, MD, PhD, Emory University
- Yueming Li, PhD, Memorial Sloan Kettering Cancer Center
- Brendan P. Lucey, MD, Washington University School of Medicine
- Shannon Macauley-Rambach, PhD, University of Kentucky
- Edoardo Marcora, PhD, Icahn School of Medicine at Mount Sinai
- John M. Olichney, MD, University of California, Davis
- Matthew Rowan, PhD, Emory University
- David P. Salmon, PhD, University of California, San Diego
- Melanie Samuel, PhD, Baylor College of Medicine
- Gerard Schellenberg, PhD, University of Pennsylvania School of Medicine
- Aristeidis Sotiras, PhD, Washington University School of Medicine
- Russell Swerdlow, MD, University of Kansas Medical Center
- Malu Tansey, PhD, Indiana University
- Julia TCW, PhD, Boston University
- Gopal Thinakaran, PhD, University of South Florida
- Robert Vassar, PhD, Northwestern University
- Cheryl Wellington, PhD, University of British Columbia
- Donna Wilcock, PhD, Indiana University School of Medicine
- Benjamin Wolozin, MD, PhD, Boston University
- Tony Wyss-Coray, PhD, Stanford Medicine
- Riqiang Yan, PhD, University of Connecticut School of Medicine
- Tracy Young-Pearse, PhD, Brigham and Womens Hospital, Harvard Medical School
- Xiongwei Zhu, PhD, Case Western Reserve University
- Na Zhao, MD, PhD, Mayo Clinic Jacksonville
Macular Degeneration Research Scientific Review Committee
Chair:
- Michael B. Gorin MD, PhD, University of California Los Angeles
Committee Members:
- Bela Anand-Apte, PhD, Cleveland Clinic Foundation
- Robert E. Anderson, MD, PhD, Dean McGee Eye Institute
- John D. Ash, PhD, University of Pittsburgh School of Medicine
- Catherine Bowes Rickman, PhD, Duke University
- Kristen Bowles-Johnson, OD, PhD, Indiana University
- Milam Brantley Jr., MD, PhD, Vanderbilt University
- Valeria Canto-Soler, PhD, University of Colorado Anschutz Medical Campus
- Karl Csaky, MD, PhD, Retina Foundation of the Southwest
- Itay Chowers, MD, Hadassah Medical Center (Israel)
- Sarah Doyle, PhD, Trinity College (Ireland)
- Steven J. Fliesler, PhD, University at Buffalo, Jacobs School of Medicine & Biomedical Sciences
- Joelle Hallak, PhD, University of Illinois
- James Handa, MD, Wilmer Eye Institute, Johns Hopkins University
- Daniel Hass, PhD, University of Washington
Committee Members (cont.)
- Joe G. Hollyfield, PhD, Cleveland Clinic Foundation
- Yali Jia, PhD, Oregon Health & Science University
- Sangeetha Kandoi, PhD, Johns Hopkins University
- Aparna Lakkaraju, PhD, University of California, San Francisco
- Theodore Leng, PhD, Stanford Medicine
- Alfred S. Lewin, PhD, University of Florida
- Abdel Majdoubi, PhD, Yale University
- Robert Mullins, PhD, University of Iowa
- Martha Neuringer, PhD, Oregon Health & Science University
- Nancy J. Philp, PhD, Thomas Jefferson University
- Przemyslaw (Mike) Sapieha, PhD, University of Montreal (Canada)
- Florian Sennlaub, MD, PhD, Institut De La Vision (France)
- Lois Smith, MD, PhD, Boston Children’s Hospital
- Karl Wahlin, PhD, University of California, San Diego
National Glaucoma Research Scientific Review Committee
Co-Chairs:
- Adriana Di Polo, PhD, University of Montreal (Canada)
- John C. Morrison, MD, Oregon Health & Science University
Committee Members:
- Dong Feng Chen, PhD, Harvard Medical School
- Abbot F. Clark, PhD, University of North Texas
- Crawford Downs, PhD, University of Alabama
- C. Ross Ethier, PhD, Emory Eye Center, Emory School of Medicine
- Michael Fautsch, PhD, Mayo Clinic, Rochester
- Brad Fortune, OD, PhD, Devers Eye Institute
- Thomas F. Freddo, OD, PhD, Wilmer Eye Institute, Johns Hopkins University School of Medicine
- Kimberly Gokoffski, MD, University of Southern California
- Michael Hauser, PhD, Duke University
- Yi Hua, PhD, University of Mississippi
- Denise Inman, PhD, University of North Texas
- Tatjana Jakobs, MD, Harvard Medical School
- Hari Jayaram, PhD, Moorfields Eye Hospital
- Kate Keller, PhD, Oregon Health & Science University
- Rachel Kuchtey, MD, PhD, Vanderbilt University Medical Center
Committee Members (cont.)
- Richard Libby, PhD, University of Rochester
- Paloma Liton, PhD, Duke University
- Prabhavathi Maddineni, PhD, University of Missouri-Columbia
- Nicholas Marsh-Armstrong, PhD, University of California, Davis
- Colleen McDowell, PhD, University of Wisconsin–Madison
- Stuart J. McKinnon, MD, PhD, Duke University
- Gillian McLellan, BVMS, PhD, University of Wisconsin–Madison
- Jason Meyer, PhD, Indiana University
- James Morgan, MA DPhil BM BCH FRCOphth, Cardiff University
- Robert W. Nickells, PhD, University of Wisconsin–Madison
- Yvonne Ou, MD, University of California, San Francisco
- Babak Naghizadeh Safa, PhD, University of South Florida
- Rebecca Sappington, PhD, Wake Forest University
- Ian Sigal, PhD, University of Pittsburgh School of Medicine
- W. Daniel Stamer, PhD, Duke University
- James N. Ver Hoeve, PhD, University of Wisconsin–Madison
- Darrell WuDunn, MD, PhD, University of Florida College of Medicine
News
Recent News & Information
Press Release
2025 Research Portfolios Spotlight Breakthrough Science
BrightFocus is proudly supporting 186 cutting-edge research grants, fueling the global fight against Alzheimer’s disease, macular degeneration, and glaucoma.
Article
2025 Annual Report Now Available
BrightFocus Foundation’s 2025 annual report celebrates groundbreaking research and public awareness.
Article
BrightFocus Foundation Welcomes New Director of Vision Science Programs
Jimmy Liu, PhD, has joined BrightFocus as Director of Vision Science Programs, bringing deep expertise in eye disease research and a passion for advancing the next generation of vision treatments.
Press Release
New Public Service Campaign Encourages Eye Exams to Save Sight
BrightFocus Foundation's new national public service announcements raise awareness of macular degeneration and glaucoma, leading causes of irreversible blindness among people age 50 and older in the U.S.
Article
Standing Together to Protect Progress: BrightFocus Statement on 2026 National Institutes of Health and National Eye Institute Appropriations
The proposed 2026 federal budget released by the Trump administration would deliver crippling cuts to the National Institutes of Health (NIH). These cuts would threaten essential progress in the fight against Alzheimer’s disease, macular degeneration, and glaucoma—diseases of mind and sight impacting 1 in 7 Americans over age 40.
Article
BrightFocus Statement on Senate Passage of the One Big, Beautiful Bill Act
Legislation jeopardizes health care for millions of Americans living with Alzheimer’s, macular degeneration, glaucoma, and other serious conditions.